Research progress on molecular biomarkers of lung adenocarcinomas
Lung cancer is the leading cause of cancer-related deaths worldwide.Lung adenocarcinomas,with a hidden onset and strong invasiveness,are the most common type of lung cancers that pose a serious threat to lives and health.Molecular targeted therapy is the optimal therapeutic strategy for lung adenocarcinomas relying on the molecular basis of carcinogenesis and development of biological platforms to recognize new biomarkers.In this paper,we reviewed the existing techniques for detecting molecular markers of lung adenocarcinomas and their mechanisms of action in the occurrence and development of lung adenocarcinomas,and therapeutic strategies based on these markers,aiming to provide ideas for the clinical diagnosis and treatment of lung adenocarcinomas.
lung adenocarcinomabiomarkerstargeted therapymolecular mechanismnon-small cell lung cancer
NETL
NSTL
万方数据
